With certain cancers increasing in the U.S., incorporating ways to lower your chance of developing one is key. Now, new ...

Oral ANAVEX ® 3-71 is a dual SIGMAR1 receptor agonist and M1 positive allosteric modulator with agonistic effects. This novel mechanism of action offers the potential to treat all symptom domains of ...

A closely watched clinical trial testing what could be the world’s first new tuberculosis vaccine in a century has hit its ...

"Enrollment pace and clinical investigator interest in our Bria-ABC study is above any I have seen,” noted Giuseppe ... under ...

The NIH has spent millions of dollars studying the effects of puberty blockers on transgender-identifying children.

SAN DIEGO -- Administering fecal microbiota via colonoscopy instead of rectally prevented recurrence of Clostridium difficile ...

Vera Therapeutics, Inc. VERA said on Wednesday that it had completed full enrollment (431 participants ... through 104 weeks in the full study population. In addition, the company is currently ...

Financing follows completion of enrollment of Phase 3 NATiV3 study evaluating lanifibranor in MASH and satisfaction of other specified c ...

Hospitalizations cut by 59% for high-risk patients using University of Michigan’s home monitoring program. $12 million retu ...

Many women already know that preeclampsia—a dangerous form of high blood pressure during pregnancy—can lead to serious ...